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In mammals, there are two types of urea transporters; urea transporter (UT)-A and UT-B.
The UT-A transporters are mainly expressed in kidney epithelial cells while UT-B demon-
strates a broader distribution in kidney, heart, brain, testis, urinary tract, and other tissues.
Over the past few years, multiple urea transporter knockout mouse models have been
generated enabling us to explore the physiological roles of the different urea transporters.
In the kidney, deletion of UT-A1/UT-A3 results in polyuria and a severe urine concentrating
defect, indicating that intrarenal recycling of urea plays a crucial role in the overall capac-
ity to concentrate urine. Since UT-B has a wide tissue distribution, multiple phenotypic
abnormalities have been found in UT-B null mice, such as defective urine concentration,
exacerbated heart blockage with aging, depression-like behavior, and earlier male sexual
maturation. This review summarizes the new insights of urea transporter functions in dif-
ferent organs, gleaned from studies of urea transporter knockout mice, and explores some
of the potential pharmacological prospects of urea transporters.
Keywords: knock out mouse, urea transport, urea transporter inhibitor, urinary concentrating mechanism
Urea, a small highly polar molecule (MW≈ 60 Da), is the major
end product of nitrogen metabolism. Urea is generated from the
ornithine cycle in liver, and is ultimately excreted by the kidney
representing 90% of total nitrogen in urine. The remaining 10%
waste nitrogen is largely composed of uric acid and ammonium
(Fenton, 2008).
Urea has been thought to cross the cell membrane by simple
diffusion for 30 years. However, a permeability study revealed that
urea crossing artificial lipid bilayers is actually very low, only at
4× 10−6cm/s (Gallucci et al., 1971). Considering the high con-
centration of urea in human (285 mmol/L), rat (700 mmol/L),
and mouse (1800 mmol/L) urine, the amount of urea in the urine
should inevitably cause osmotic diuresis in the renal collecting
ducts. This scenario does not happen in vivo. Gamble et al. (1934)
discovered that kidneys have an ability to excrete high concentra-
tions of urea without taking away corresponding water, indicating
that simple diffusion was not the only way for urea across the
membrane. Direct physiological evidence from a renal tubular
perfusion experiment by Sands and Knepper (1987) demonstrated
the existence of urea permeability in the terminal inner medullar
collecting duct that was higher than the level accounted for with
simple diffusion. This led to the discovery of the facilitative urea
transporters (UTs). You et al. (1993) cloned the first facilitative UT.
GENETIC CHARACTERISTICS OF UREA TRANSPORTERS
The two UT subfamilies of UT-A and UT-B are encoded by Slc14a2
and Slc14a1 gene, respectively. In human, both UT genes are
located on chromosome 18 (Fenton et al., 1999; Smith and Fenton,
2006). The UT-A family has six members, UT-A1 through UT-A6,
and at least two distinct promoters, UT-Aα and UT-Aβ (Timmer
et al., 2001; Bagnasco, 2003). UT-Aα is in the 5′-flanking region of
UT-A gene (Timmer et al., 2001) and responsible for UT-A1, UT-
A3, and UT-A4 gene transcription. Structurally, these three forms
share an identical N-terminal part but are diverse in C-terminal
ends. The UT-A1 stop codon is located in exon 24, the last exon
of the UT-A gene, which makes UT-A1 the largest form in this
family (Fenton et al., 2002b). The UT-A3 stop codon is in exon
13. UT-A1 does not possess exon 13 avoiding early termination of
UT-A1 translation (You et al., 1993). UT-A4 gene is only identi-
fied by RT-PCR due to its low abundance in kidney (Smith et al.,
2004). The gene encoding UT-A2 possesses a start site in exon 14
that is distinct from other members in the family. UT-A2 shares
an identical C-terminal site with UT-A1 and UT-A4 (Karakashian
et al., 1999). UT-A2 is regulated by the UT-Aβ promoter in intron
13 (You et al., 1993). UT-A5 is reported in mouse testis and has
the identical C-terminus of UT-A3 (Olives et al., 1994). In human,
UT-A6 is identified in colonic cells and is the smallest member of
UT-A family with 216 amino acids (Bagnasco, 2003).
Urea transporter-B is the only transcription product of Slc14A1
gene in human, mouse, and rat. In 2009, the crystal structure
of UT-B was determined (Levin et al., 2009). The membrane-
spanning pore consisting of two halves of the protein has a filter
to select proper molecules to pass. To compensate for the energy
used in dehydration, there are hydrogen bonds between urea and
oxygen atoms in the principal-chain and side-chain of the UT-
B molecule, as well as interactions between α-helix dipoles and
amide-pi (Levin et al., 2009).
UT TISSUE DISTRIBUTION AND REGULATION
Urea transporter-A1 is distributed in the apical membrane
of the middle and terminal inner medullary collecting duct
(IMCD) cells (Figure 1; Shayakul and Hediger, 2004). The large
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FIGURE 1 | Diagram depicting the vascular and tubular routes of urea
recycling within the kidney. A short and a long-loop of Henle are depicted
within the four kidney zones, along with a descending vasa recta (DVR) and
an ascending vasa recta (AVR). OM is defined as outer medulla. In normal
mice, concentrated urea is delivered to the tip of the papilla by the terminal
part of the collecting ducts expressing the vasopressin-regulated urea
transporters UT-A1/3. Urea is taken up by ascending blood (plasma and red
blood cells) in AVR, and a significant fraction of it is returned to the IM by
being reintroduced either in the DVR (expressing UT-B) or in the descending
thin limbs of Henle’s loops (expressing UT-A2). Reproduced from Lei et al.
(2011).
intracellular hydrophilic loop of UT-A1 contains several PKA
and PKC consensus phosphorylation sites (Shayakul and Hediger,
2004). Consistently, cAMP and cAMP agonists, such as vaso-
pressin, forskolin, and IBMX have been reported to stimulate
UT-A1 urea transport activity (Frohlich et al., 2006). In addition,
hyperosmolarity- and angiotensin II-stimulated UT-A1 activation
is by a PKC mediated pathway (Kato et al., 2000; Wang et al.,
2010; Klein et al., 2012). Lithium can stimulate UT-A1 activity
but does not activate the cAMP signaling pathway (Frohlich et al.,
2008).
Urea transporter-A2 is expressed in the thin descending limbs
(TDL) of Henle’s loop, containing short-loop nephrons in the
inner stripe of the outer medulla and long-loop nephrons in the
base of the inner medulla (IM; Wade et al., 2000). UT-A2 can-
not only be acutely stimulated by cAMP, vasopressin, or increased
intracellular calcium (Potter et al., 2006), but is also chronically
up-regulated by vasopressin (Wade et al., 2000). Rat UT-A3 has
been reported to localize IMCD cells in the apical membrane as
well as intracellularly (Terris et al., 2001). However in mice, it is
also expressed in the basolateral membrane of IMCD cells (Stew-
art et al., 2004). UT-A3 is sensitive to acute stimulation by the
cAMP signaling pathway (Shayakul and Hediger, 2004). Chronic
vasopressin infusion can increase UT-A3, as well as UT-A1, mRNA,
and protein expression (Cai et al., 2010). UT-A4 is expressed in the
renal IM in rat but its exact distribution is unclear. In vitro studies
show that UT-A4 is also stimulated by the cAMP signaling pathway
(Karakashian et al., 1999). UT-A5 is exclusively expressed in the
peritubular myoid cells of the outermost layer of the seminiferous
tubules (SMTs) in testes (Fenton et al., 2000, 2002a). UT-A6 is
only characterized in human colonic mucosa. Although lacking a
common PKA phosphorylation consensus site, UT-A6 is sensitive
to cAMP and cAMP agonists (Bagnasco, 2003). UT-A transcripts
are also detected in brain, heart, and liver (Fenton et al., 2002b),
but the function and characteristic of the extra-renal UT-A has
been less explored.
Urea transporter-B has a wide tissue distribution. In the kid-
ney, it is located in the endothelial cells of descending vasa recta
(DVR; Pallone, 1994; Tsukaguchi et al., 1997; Xu et al., 1997).
In brain (Couriaud et al., 1996) UT-B mainly expresses in astro-
cytes, ependymal cells, as well as subgroups of neurons in dorsal
root ganglia and the inferior colliculus, and cells in the anterior
pituitary gland (Berger et al., 1998). The erythrocyte membrane
contains abundant UT-B (Olives et al.,1994),which not only medi-
ates rapid movement of urea across red blood cells, but also serves
as a Kidd (JK) antigen (Olives et al., 1995; Timmer et al., 2001). In
addition, UT-B is found in colon (Inoue et al., 2004), sertoli cells
in testis (Fenton et al., 2002a), heart, liver, spleen, lung, stomach
(Lucien et al., 2005), and epithelial cells in urinary tract including
bladder, ureter, and pelvis lumens (Spector et al., 2004). UT-B is
down-regulated by dDAVP, an agonist of the type II vasopressin
receptor (Trinh-Trang-Tan et al., 2002).
Urea transporter-A expression is observed early in 1-day-old
neonates while UT-B is not detected until the fetus is 20 days old
(Kim et al., 2002). UT-A2 expression is up-regulated in UT-B null
mice (Klein et al., 2004). The urea transport activity of all six UT-A
members and UT-B is inhibited by phloretin (Olives et al., 1994;
Klein et al., 2004).
PHYSIOLOGICAL ROLE OF UTs
KIDNEY: URINE CONCENTRATING MECHANISM
Urine concentration in the kidney is a complicated process involv-
ing many solutes, such as urea, Na+, K+, Cl−, etc. (Chou and
Knepper, 1989). Of all these solutes, urea plays a key role by
recycling in the renal medulla (Sands, 2002).
Figure 1 illustrates the intrarenal urea recycling (Lei et al.,
2011). As urine flows along the collecting duct, water is absorbed
through water channels (AQPs), resulting in a high urea concentra-
tion in the terminal IMCD. There, the urea is rapidly reabsorbed
by UTs UT-A1 and UT-A3. This process is regulated by vaso-
pressin and is important to maintain high urea concentration in
inner medullary interstitium and to set up the intrarenal osmotic
gradient. The reabsorbed urea enters ascending vasa recta (AVR)
where the endothelium has micropores permeable to urea. Urea is
transferred from AVR to DVR through UT-B in a countercurrent
exchange that helps to preserve the urea concentration gradient in
IM (Yang and Bankir, 2005). In addition, UT-A2 expressed in TDL
also mediates urea transport from the lumen to the interstitium,
where the urea eventually goes back to the IM through DVR. The
entire urea recycling is carried out in concert by UT-A1, UT-A3 in
terminal IMCD, UT-A2 in TDL, and UT-B in DVR, and enables
the kidney to establish the hyperosmotic gradient in the IM.
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The vital roles of UTs in intrarenal urea recycling and the
urine concentrating mechanism have been confirmed by knock-
out mouse models. In UT-B null mice, the urea clearance rate is
reduced by 25% while the urea concentration increases by 30%
and urea concentration in urine decreases by 35%. The UT-B
null mice demonstrate higher urine output than wild-type mice
(Figure 2; Bankir et al., 2004; Yang and Bankir, 2005; Lei et al.,
2011). Moreover, the urinary urea concentration and the osmo-
lality are not elevated in response to acute urea load (Figure 3),
indicating that urea cannot be efficiently concentrated and water
cannot be preserved in the absence of the UT-B. UT-B deletion
causes a urea-selective urinary concentrating defect (Yang et al.,
2002; Yang and Bankir, 2005). This fact could prove very promis-
ing in developing diuretics that specifically inhibit UT-B activity.
Of note, UT-B expressed on the erythrocyte membrane also signif-
icantly contributes to the urine concentrating mechanism, which
will be discussed later.
Urea transporter-A2 null mice are not different from wild-type
mice in urine concentrating ability under normal conditions. A
reduction in urea accumulation in the IM was observed only when
a low-protein diet was applied, which reduced urea production
(Yang et al., 2002). UT-A2 was thought to mediate urea exit from
AVR to TDL. However, comparing the phenotype between UT-B
FIGURE 2 | Urea transporter-B knockout and UT-A2/UT-B knockout
mouse models. (A)Twenty-four hours urine output in mice of indicated
genotype. (B) Urine osmolality measured in mice given free access to food
and water (basal) and after an 18-h water deprivation (right; n=6
mice/group, means±SE, *p<0.01 compared with WT mice. #p<0.01
compared with UT-B KO mice). (C) Urea concentration, sodium
concentration, potassium concentration, and chloride concentration in
homogenized IM (means±SE, n=6. *p<0.01 compared with WT mice.
#p<0.01 compared with UT-B KO mice). Reproduced from Lei et al. (2011).
null mice and UT-A2 null mice, the previously proposed role of
UT-A2 needs to be further assessed (Uchida et al., 2005). The
UT-A2 and UT-B double knockout (UT-A2/B−/−) mouse is a
good model for determining the role of UT-A2 by comparing UT-
A2/B−/− and UT-B−/− (Lei et al., 2011). As shown in Figure 2,
urine output, urine osmolality, and urea concentration in IM at
both basal and water-deprived conditions in UT-A2/B−/− mice
were between those in UT-B−/− mice and wild-type mice. The
phenotype of UT-A2/B−/− mice after acute urea load was also
between that of UT-B−/− mice and wild-type mice (Figure 3).
These results show that UT-A2 and UT-B contribute to urea
cycling in an opposing way, that is, UT-A2 mediates urea transport
from the lumen to the interstitium. This hypothesis requires an
outward-directed concentration gradient from TDL to the inter-
stitium, which might be provided by active secretion to the pars
recta. Further studies are needed to clarify this hypothesis.
Urea transporter-A1 and UT-A3 double knockout (UT-
A1/3−/−) mice were generated by gene targeting strategy (Fenton
et al., 2004). UT-A1/3−/− mice had significantly higher urine
output and water intake than wild-type mice in high-protein and
normal-protein feeding conditions but not with low-protein feed-
ing. After an 18-h water deprivation, reduced urine output was
observed in UT-A1/3−/− in low-protein fed mice but not in
mice under high-protein and normal-protein conditions (Fen-
ton and Knepper, 2007; Fenton, 2008). These findings suggest that
the diuresis that occurs in UT-A1/3−/− mice is due to the high
urea concentration accumulated in the lumen, which supports the
hypothesis that UT-A1 and UT-A3 mediate the rapid urea trans-
port from the lumen of the IMCD to the interstitium. Fenton
has an excellent review discussing the UT-A1/A3 knockout mouse
(Fenton and Knepper, 2007).
FIGURE 3 | Effect of acute urea loading on urinary concentrating
activity and renal handling of urea inWT, UT-B KO, and UT-A2/B KO
mice.Three-hundred micromolar urea were injected intraperitoneally just
after the first 2 h urine collection (time 0), and urine was then collected for
four more 2 h periods. (A) Urine osmolality (Uosm). (B) Urine output. (C)
Urine urea concentration (Uurea). (D) Plasma urea concentration P urea. Values
are expressed as means±SE, n=6/group. *p<0.01 compared with WT
mice, #p< 0.01 compared with UT-B KO mice. Reproduced from Lei et al.
(2011).
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ERYTHROCYTES
Erythrocyte membranes have high urea permeability, which is
1.1± 0.2× 10−5 cm/s in human and 3.3± 0.4× 10−5 cm/s in
rodents (Sands, 2002). To maintain the cell osmotic stability,
urea must transverse erythrocyte membranes rapidly (Macey and
Yousef, 1988; Fenton et al., 2005) when erythrocytes pass through
vasa recta from the cortex to IM. The high efficiency of UT-B
expressed in erythrocytes prevents the cells from shrinking in
the IM where urea concentration accumulation is 50- to 200-
fold higher than that in peripheral blood (Sands, 2002), and
subsequently swelling after the cells leave the hyperosmotic envi-
ronment. However, the role of UT-B in erythrocyte survival is
currently speculative. Theoretical calculations and in vivo studies
show that only about 0.5% of the total cardiac output of ery-
throcytes pass through the vasa recta (Lieberthal et al., 1987).
Moreover, erythrocyte survival is not affected by either increased
or decreased urine concentrating ability (Liu et al., 2011).
Urea transporter-B in erythrocytes also plays an important role
in the urine concentrating mechanism. Lieberthal et al.’s (1987)
study shows that urine cannot be well concentrated in the isolated
kidney perfused without erythrocytes. The concentrating ability
is restored after adding erythrocytes to the perfusate. The pres-
ence of UT-B enables rapid urea intake and release into and out
of erythrocytes in the IM as they circulate away from the IM. This
process helps build the urea concentration gradient. In addition,
the countercurrent exchange between AVR and DVR, which con-
serves urea in the kidney, also depends on rapid urea transport
through erythrocytes.
Urea transporter-B transports a number of urea analogs, such
as formamide, acetamide, thiourea, and methylurea, with various
rates (Figure 4; Zhao et al., 2007). By competing with high affin-
ity to UT-B, urea analogs decrease UT-B urea permeability and
result in UT-B blockage (Goodman, 2002). Thiourea, one of the
analogs of urea, was shown to have a 10-fold greater binding affin-
ity to UT-B than urea (Zhao et al., 2007). Of note, erythrocytes
have high water permeability mainly mediated by water chan-
nel AQP1 (Yang et al., 2001). UT-B is also permeable to water
(Figure 5A; Yang and Verkman, 1998). The low water permeabil-
ity found in AQP1/UT-B double knockout erythrocytes was also
seen after HgCl2 treatment of UT-B null erythrocytes or phloretin
treatment of AQP1 null erythrocytes (Figure 5B; Yang and Verk-
man, 2002). The single channel water permeability of UT-B is
7.5× 10−14 cm3/s, similar to that of AQP1 (Yang et al., 2001),
which provides direct functional evidence for UT-B-facilitated
water transport in erythrocytes and suggests that urea traverses an
aqueous pore in the UT-B protein (Figure 5C; Yang and Verkman,
1998).
HEART
Three different sizes of UT-A proteins, 39, 51, and 56 kDa in rats
and 51, 56, and 97 kDa in human, are found in heart when blot-
ting the heart tissue with UT-A1 antibody (Duchesne et al., 2001).
However, the type of UT-A isoforms is still undetermined. The
56-kDa protein is up-regulated in the uremia and hypertensive rat
models. In human, both of 56 and 51 kDa protein expression are
increased in heart failure caused by dilated cardiomyopathy.
FIGURE 4 | Urea analog permeability mediated by UT-B. Erythrocyte
solute permeability measured by stopped-flow light scattering. (A)
Representative curves for the time course of scattered light intensity at 10˚C
in response to a 250-mM inwardly directed gradient of urea. (B) Averaged
solute permeability coefficients (Ps) for experiments done as in panel A
(mean±S.E., n=3). Reproduced from Zhao et al. (2007).
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FIGURE 5 |Water and urea permeability mediated by aquaporins and
urea transporters. (A). Water and urea permeability in oocytes expressing
aquaporins and urea transporters. Time course of oocyte swelling was
measured at 10˚C in response to a fivefold dilution of extracellular Barth’s
buffer with distilled water. Oocytes were injected with 50 nL of water (as
control) or cRNAs (5 ng) encoding AQP1, AQP3, UT-A2, or UT-B. (B)
Erythrocyte water permeability (P f) measured by stop-flow light scattering
based on the time course of changes in erythrocyte volume in response to a
250-mM inwardly directed sucrose gradient. These data were obtained in
erythrocytes from mice of indicated genotype at 10˚C, under control
conditions and in the presence of 0.3 mM HgCl2 or 0.7 mM phloretin. Values
are expressed as means±SE, n=3 mice/genotype. *p<0.01 compared
with no inhibitor. #p<0.01 compared with WT in control conditions P f. (C)
Relative contributions of AQP1, UT-B, and the lipid bilayer to erythrocyte
water and urea permeability at 10˚C. Reproduced from Yang and Verkman
(1998, 2002).
Urea transporter-B is highly expressed in hearts. ECG record-
ing shows that the UT-B knockout mouse has a prolonged P-R
interval from early (6 week) to old ages (52 weeks), indicating that
the conduction from atrium cordis to cardiac ventricle is delayed
(Figures 6A,B). However, UT-B deletion results in increased
type II and III atrial ventricular heart block attack only in the
aged mice (>52 weeks). The significantly reduced APA and V max
demonstrate that the cardiocyte excitability and conductibility are
impaired in UT-B null mice (Yu et al., 2009). The accumulated
urea in cells might be involved in the progressive heart block in
UT-B null mice (Meng et al., 2009). However, the causative role of
urea accumulation in cardiac disease is still in debate (Scheuer and
Stezoski, 1973). One in vitro study shows that urea at 3–300 mM
had a protective effect to heart damage induced by ischemia and
electrolysis (Wang et al., 1999). Other possible mechanisms may
exist. Interestingly, TNNT2 (Troponin T Type 2) is significantly
increased in UT-B null hearts (Hershberger et al., 2009). TNNT2
is an important factor in heart that acts as a Ca2+ sensor (Yu et al.,
2009) and affects the contractility of myocardium (Sehnert et al.,
2002). The increased TNNT2 might be involved in the develop-
ment of heart block in UT-B null mice. Atrial natriuretic peptide
(ANF) is increased in aged UT-B knockout mice (>52 weeks;
Figure 6C; Meng et al., 2009). ANP is regarded as a hypertro-
phy protective factor (Oliver et al., 1997; Horio et al., 2000) and
hypertrophy is related to the heart block (Moak et al., 2001).
BRAIN
Urea transporter-B is expressed in brain, mainly in astrocytes and
ependymal cells. Brain contains a high concentration of urea, the
same as seen in liver (Buniatian and Davtian, 1966). Intriguingly,
UT-B is not detected in endothelial cells of blood vessels which
form the blood-brain barrier (BBB). Indeed, the permeability of
urea across BBB is relatively slow and reversible (Kleeman et al.,
1962). Urea mediated by UT-B enters into the astrocytes, passes
through the ependymal cells, and finally gets into the cerebrospinal
fluid (CSF) to be excreted (Couriaud et al., 1996). In support of
this, arginase II, the key enzyme for urea synthesis in brain, was
detected to have a larger distribution than UT-B (Braissant et al.,
1999).
In 5/6 nephrectomized uremic rat models, both UT-B mRNA
and protein in brain was significantly reduced (Hu et al.,
2000). In contrast, AQP4 and AQP9 were remarkably increased
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FIGURE 6 | Surface electrocardiogram and action potential in mice
lacking UT-B. (A)The II standard lead ECG of WT and UT-B null mice. (B)
The P-R interval in WT and UT-B null mice (mean+SD, n=20, *p<0.05 vs.
WT mice). (C)The expression level of ANP in 16- and 52-week-old WT and
UT-B null mice. Reproduced from Meng et al. (2009), Yu et al. (2009).
(Trinh-Trang-Tan et al., 2005). This might be the reason for the
rapid development of brain edema in dialysis. The reduced UT-B
in astrocytes impairs urea effusion and results in urea accumula-
tion in brain. Subsequently, the elevated osmolarity drives water to
flow into the brain through the water channels AQP4 and AQP9.
Urea transporter-B is expressed in brain (Figure 7A) and con-
trols urea concentration in brain tissue (Figure 7B; Guo et al.,
2007). UT-B may also play an important role in the regulation
of nitric oxide (NO) production in brain. Urea has an inhibi-
tive effect on l-arginine transport into the epithelial cells (Xiao
et al., 2001) and phloretin can block this inhibition (Wagner et al.,
2002). UT-B likely mediates urea transport and regulates intra-
cellular l-arginine concentration. UT-B null mice present both
depression-like behavior (Li et al., 2012) with an extended immo-
bility time in forced swim test (Figure 7C) and less interest in
sucrose in a sucrose preference test (Figure 7D). Decreased rCBF
(cerebral blood flow) supports the hypothesis of “vascular depres-
sion” (Figure 7E). Histologically, swelling of unmyelinated fibers
was observed in hippocampus. This change may reflect the degen-
eration of membrane structures and impaired axoplasmic trans-
port which contribute to the depressed-like behavior (Figure 7F).
Notably, the UT-B null mouse has decreased NO production in
brain and increased urea concentration especially in hippocampus
in both acute urea load tests and normal condition (Figure 7B).
Acute urea load decreases nNOS expression (Li et al., 2012).
TESTIS
Urea transporter-A5 is reported in testis. However, Northern blot
analysis revealed different UT-A mRNA transcripts at 4.0, 3.3, 2.8,
and 1.7 kb in testis (Tsukaguchi et al., 1997), which are all longer
than UT-A5. This suggests that other types of UT-A isoforms may
also exist. UT-A proteins were found in the nuclei of Sertoli cells
throughout development of the seminiferous tubules (SMT) as
well as in the residual bodies at stage VIII of SMT (Fenton et al.,
2002a). Considering that the Sertoli cell nuclei do not produce
urea, the function of UT-A in the nuclei is unclear and may not
be related to urea transport. The residual bodies are involved in
the formation of the spermatozoa head while spermatids trans-
form into spermatozoa. This process requires a reduction of cell
volume. UT-A in residual bodies probably participates in reducing
cell volume by rapidly excreting urea, while water channel AQP7
and AQP8 excrete fluid. In support of this, UT-A1 and UT-A3
double knockout mice have enlarged testis (Fenton et al., 2005).
Interestingly, UT-A5 protein increases at day 20 after birth, the
same time when SMT begins to produce fluid to drive sperm to
reproductive tracts.
Urea transporter-B mRNA also expresses in Sertoli cells and
increases on stage II–III of SMT development. In vitro study shows
phloretin-inhibited urea diffusion across Sertoli cells and SMT cell
membranes following the concentration gradient of urea (Guo
et al., 2007). In UT-B knockout mice, urea was significantly accu-
mulated in the testis (Figure 8A). After 5 min of injection, [14C]
urea accumulation in testis was significantly less in UT-B null mice
compared to the wild-type mice (Figure 8B). This suggests that
urea transport across SMT epithelia and exit from Sertoli cells
is decreased in the absence of UT-B (Guo et al., 2007). UT-B null
mouse has a larger testis and earlier breeding time (Figures 8C,D).
URINARY TRACT
Urea transporter-B is identified in urinary tract epithelial cells
both in the cell membrane and some cytoplasmic vesicles (Lucien
et al., 2005). Diets with different contents of protein or sodium do
not affect the expression of UT-B in bladder and ureter. However,
hydropenia causes a significant increase of UT-B expression in
ureter, but not bladder. Considering that bladder and ureter have
higher urea and creatinine concentration than those in plasma, the
reabsorption of urea and creatinine from luminal urine to urinary
tissue may exist (Spector et al., 2007). The high concentration of
urea may diffuse to the epithelial cells where the urea is then trans-
ported across the basolateral membrane to the muscular layer and
enter into the capillaries by UT-B UT. In terms of this, UT-B may
be involved in the regulation of epithelial cell volume and osmolal-
ity (Lucien et al., 2005). Both UT-A mRNA and protein are found
in rat bladders (Doran et al., 2006), suggesting that UT-A might
participate in the transportation of urea from urine to the apical
membranes of epithelial cells.
Interestingly, new studies reported that UT-B might be associ-
ated with urinary bladder cancer (UBC; Garcia-Closas et al., 2011;
Rafnar et al., 2011). A novel UBC susceptibility locus is found
on chromosome 18q12.3 where SLC14A1 localizes (Garcia-Closas
et al., 2011; Rafnar et al., 2011). Urine volume and frequency of
urination, which is partly regulated by UT-B, may affect the risk
of UBC occurrence.
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FIGURE 7 | Mice lacking UT-B display depression-like behavior. (A)
UT-B mRNA expression in indicated brain regions determined by
RT-PCR. α-actin was used as reference control. (B) Urea concentrations
in Olf, olfactory bulb; Cor, cortex; Hip, hippocampus; Hypo,
hypothalamus. Mean±SE, *p<0.05, **p<0.01, ***p<0.001,
compared with heterozygous mice, n=10. (C) Forced swim test.
Immobility time was recorded for 5 min. (D) Sucrose preference test.
Mean±SE, n=15. (E) rCBF was assessed by laser Doppler flowmetry.
Mean±SE, n=10. (F) Representative transmission electron
microscopic images of the hippocampus, which show swelling of
unmyelinated fibers with myelin figure in UT-B null mice. Reproduced
from Li et al. (2012).
LIVER
Liver is the major organ for urea synthesis. There are two different
sizes of UT-A protein identified in liver and isolated hepatocytes
from rats, mice, and chimpanzees (Klein et al., 1999). In uremic
rats, the 49-kDa UT-A protein mainly expressed in the cell mem-
brane was significantly increased, while the 36-kDa cytosolic UT-A
protein did not show any change (Klein et al., 1999). UT-B is
also reported to be expressed in liver (Sands, 2000). How the UT
mediates urea transport in liver is not clear.
INTESTINE
Urea transporter-B is expressed at the apical membrane of super-
ficial epithelial cells and crypts in colon and small intestine. How-
ever, the expression of UT-A in intestine is still controversial (Inoue
et al., 2005). Colon is believed to be permeable to urea (Moran and
Jackson, 1990). Intraluminal urea infiltrated from blood is partly
decomposed by intestinal flora into ammonia and carbon diox-
ide. Ammonia is then reabsorbed back into blood to participate in
further metabolic reactions, which accomplishes nitrogen reuti-
lization (Spector et al., 2004). Intestinal UT-B protein abundance
is increased in rats when fed a low-protein diet or a 20% urea diet,
but there is no change in UT-B abundance in animals fed a high-
protein diet or in rats with uremia (Inoue et al., 2005). Intestinal
UT-B mediates the urea movement across intestinal epithelial cells
according to transepithelial urea flux assays in vitro (Spector et al.,
2004).
PHARMACOLOGICAL PROSPECT
UT-B INHIBITOR
Urea plays an important role in the urinary concentration
mechanism. Development of a UT inhibitor may have clini-
cal significance in treating water overloaded diseases. Phloretin
is a commonly used UT-B inhibitor experimentally, but its
broad inhibitory activity, including inhibition transport of glu-
cose (Lefevre and Marshall, 1959) and glycerol (vom Dahl and
Haussinger, 1997), impedes its usage as a UT-B inhibitor. Urea
analogs, such as methylurea, thiourea, and dimethylurea, compet-
itively inhibit UT-B urea transport, usually at high concentrations
(Zhao et al., 2007). The Verkman group has published some poten-
tially promising reagents (Levin et al., 2007). By high-throughput
screening, they identified some UT-B inhibitors and successfully
established an erythrocyte osmotic lysis assay to evaluate these
compounds. Human RBCs were preloaded with urea or urea
analogs (acetamide), then the cells were changed to an isosmotic
solution without urea. Under normal conditions, urea exits the
cells through UT-B. However, in the presence of UT-B inhibitors,
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FIGURE 8 | Early maturation in the male reproductive system in UT-B null
mice. (A) Urea concentration in plasma and homogenized tissues. Tissues
from 84-day-old mice were homogenized in water. Urea concentrations in
supernatants of centrifuged homogenates were measured. (B) Kinetics of
[14C] urea uptake and organ morphology in wild-type vs. UT-B null mice. After
renal blood flow was blocked, a bolus of [14C] urea was injected intravenously,
and the blood, brain, liver, spleen, and testis were sampled at 5 min. [14C] urea
accumulation in different tissues was normalized to serum. Values are
expressed as means±SE (n=4 mice). *p<0.01 vs. WT mice. (C)
Age-related changes in testis weights. The left testis were isolated and
weighed. The x -axis shows the age of the mice, and the y -axis shows the
testis percentage of body weight (n=6, *p<0.05). (D) Breeding
performance of maturing male mice. Male (M) mice at 35 days of age were
housed with 10-week-old WT female (F) mice. Data are shown as means±SE
for seven pairs of competing mates (left ) and seven pairs of WT controls
(right ). Reproduced from Guo et al. (2007).
urea accumulates in the cells. Water enters the cells through AQP1
resulting in swelling and cell lysis. This could be measured by near-
infrared light scattering. Of note, UT-B not only transports urea,
but also water in RBC (Figure 5), but in vitro tests show that UT-B
only participates in 8% of the total transport of water, while 90% of
water is transported by AQP1. The decrease in water permeability
resulting from the inhibition of UT-B did not significantly affect
this erythrocyte osmotic model. After optimizing chemically mod-
ified compounds, Verkman et al. reported two inhibitors blocking
UT-B but not UT-A or AQP activity. Considering the crucial role
of UT-B in urine concentration, this discovery may lead to the
development of a new type of diuretic capable of inhibiting urea
absorption without changing other solutes.
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